The licenses of several pharmaceutical practitioners have been suspended or revoked following investigations by the Enquiries and Disciplinary Committee (EDC), chaired by Dr. Richard Muthoka. The probe was initiated after complaints of professional misconduct were lodged with the Pharmacy and Poisons Board (PPB).
One of the key establishments involved, Malibu Pharmacy, faced action after a medication package was delivered with an external label revealing sensitive patient information, including the complainant’s full name, phone number, house name, and diagnosis. The package also contained an improperly coded insurance form with an incorrect diagnosis, further compromising patient privacy.
Following the hearing, the EDC ruled that this was a severe breach of professional conduct and suspended the license of Dr. Nancy Wangu Kaguri, the pharmacy’s superintendent, for six months.
In another case, pharmaceutical technologist Lovi Lovince Manono was found guilty of misconduct for entering an agreement with a non-professional to establish a pharmacy under his credentials and later transferring control to the unqualified individual. The committee deemed this a fraudulent act and revoked Manono’s license, banning him from practice for five years.
Dr. Charles Mukabi Waweru, a pharmacist in Matasia, Kajiado County, also faced disciplinary action for failing to properly close a pharmacy and leaving the premises open without a registered professional. His negligence resulted in a three-month suspension of his license.
Additionally, Emmanuel Odhiambo Gwassi was penalized for operating an unregistered pharmacy without a licensed pharmacist or pharmaceutical technologist. His pharmaceutical representative license was revoked, and he was banned from practice for five years.
The committee showed leniency in the case of Caroline Wachera, a pharmaceutical technologist accused of not notifying the Board about a pharmacy closure. Given her efforts to comply and relinquish her business partnership, she received an admonishment letter.
“The Pharmacy and Poisons Board remains committed to safeguarding public health and upholding professional standards in the pharmaceutical sector,” said Dr. Fred Siyoi, CEO of the PPB.
